Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib.
Drugs Context. 2020 Nov 16;9:2020-8-5. doi: 10.7573/dic.2020-8-5. eCollection 2020.
Drugs Context. 2020.
PMID: 33240390
Free PMC article.
Review.